Crycision
Nanning
About Crycision
Crycision is a membrane protein targeted drug developer.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $290.0K
- Funding stage: Seed
- Last round: Angel (Nov 2018)
- Website: crycision.com
Industries & Categories
Health Care
Canonical: https://fsome.com/organization/crycision-2213673 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.